Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 751349, 7 pages
http://dx.doi.org/10.1155/2014/751349
Research Article

Effects of Traditional Chinese Medicine Qinbai Qingfei Concentrated Pellet on Cellular Infectivity of Mycoplasma pneumoniae

College of Veterinary Medicine, Northeast Agricultural University, Harbin, Heilongjiang 150030, China

Received 19 June 2014; Accepted 10 September 2014; Published 29 October 2014

Academic Editor: Ayman M. Noreddin

Copyright © 2014 Guo-Zheng Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. B. Waites, D. M. Crabb, X. Bing, and L. B. Duffy, “In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 1, pp. 161–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. Wilson and A. M. Collier, “Ultrastructural study of Mycoplasma pneumoniae in organ culture,” Journal of Bacteriology, vol. 125, no. 1, pp. 332–339, 1976. View at Google Scholar · View at Scopus
  3. R. Himmelreich, H. Hubert, H. Plagens, E. Pirkl, B.-C. Li, and R. Herrmann, “Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae,” Nucleic Acids Research, vol. 24, no. 22, pp. 4420–4449, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Guleria, N. Nisar, T. C. Chawla, and N. R. Biswas, “Mycoplasma pneumoniae and central nervous system complications: a review,” Journal of Laboratory and Clinical Medicine, vol. 146, no. 2, pp. 55–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-L. Liu, G.-Q. Wang, B. Zhang et al., “Mycoplasma pneumoniae pneumonia in hospitalized children diagnosed at acute stage by paired sera,” Chinese Medical Journal, vol. 123, no. 23, pp. 3444–3450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Park, K. S. Pai, A. R. Kim, J. H. Lee, J. I. Shin, and S. Y. Lee, “Fulminant and fatal multiple organ failure in a 12-year-old boy with Mycoplasma pneumoniae infection,” Allergy, Asthma and Immunology Research, vol. 4, no. 1, pp. 55–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. H.-Y. Chang, O. A. Prince, E. S. Sheppard, and D. C. Krause, “Processing is required for a fully functional protein p30 in Mycoplasma pneumoniae gliding and cytadherence,” Journal of Bacteriology, vol. 193, no. 20, pp. 5841–5846, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Nakane, J. Adan-Kubo, T. Kenri, and M. Miyata, “Isolation and characterization of P1 adhesin, a leg protein of the gliding bacterium Mycoplasma pneumoniae,” Journal of Bacteriology, vol. 193, no. 3, pp. 715–722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Bebear, M. Dupon, H. Renaudin, and B. de Barbeyrac, “Potential improvements in therapeutic options for mycoplasmal respiratory infections,” Clinical Infectious Diseases, vol. 17, no. 1, pp. 202–207, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. K. B. Waites and D. F. Talkington, “Mycoplasma pneumoniae and its role as a human pathogen,” Clinical Microbiology Reviews, vol. 17, no. 4, pp. 697–728, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Bébéar, S. Pereyre, and O. Peuchant, “Mycoplasma pneumoniae: susceptibility and resistance to antibiotics,” Future Microbiology, vol. 6, no. 4, pp. 423–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Morozumi, T. Takahashi, and K. Ubukata, “Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia,” Journal of Infection and Chemotherapy, vol. 16, no. 2, pp. 78–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Liu, X. Ye, H. Zhang et al., “Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 2160–2162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. W. M. Wang, H. J. Zhang, and H. L. Tang, “Study on main pharmacodynamics of traditional Chinese medicine Qinbai Qingfei concentrated pellet,” Journal of Heilongjiang University of Tradition Chinese Medicine, vol. 6, pp. 42–43, 2003. View at Google Scholar
  15. K. J. Rhoden, A. M. Dodson, and B. Ky, “Stimulation of the Na+-K+ pump in cultured guinea pig airway smooth muscle cells by serotonin,” The Journal of Pharmacology and Experimental Therapeutics, vol. 293, no. 1, pp. 107–112, 2000. View at Google Scholar · View at Scopus
  16. C. Bernet, M. Garret, B. De Barbeyrac, C. Bebear, and J. Bonnet, “Detection of mycoplasma pneumoniae by using the polymerase chain reaction,” Journal of Clinical Microbiology, vol. 27, no. 11, pp. 2492–2496, 1989. View at Google Scholar · View at Scopus
  17. S. Razin and L. Hayflick, “Highlights of mycoplasma research—an historical perspective,” Biologicals, vol. 38, no. 2, pp. 183–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Krause, “Mycoplasma pneumoniae cytadherence: organization and assembly of the attachment organelle,” Trends in Microbiology, vol. 6, no. 1, pp. 15–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Martínez, M. Ruiz, E. Zunino, V. Luchsinger, R. Aguirre, and L. F. Avendaño, “Identification of P1 types and variants of Mycoplasma pneumoniae during an epidemic in Chile,” Journal of Medical Microbiology, vol. 59, no. 8, pp. 925–929, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Schurwanz, E. Jacobs, and R. Dumke, “Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development,” Infection and Immunity, vol. 77, no. 11, pp. 5007–5015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Chaudhry, A. K. Varshney, and P. Malhotra, “Adhesion proteins of Mycoplasma pneumoniae,” Frontiers in Bioscience, vol. 12, no. 2, pp. 690–699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Y. Chang, J. L. Jordan, and D. C. Krause, “Domain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motility,” Journal of Bacteriology, vol. 193, no. 7, pp. 1726–1733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. X. N. Zhao, Y. L. Hu, D. Y. Wang et al., “Optimization of sulfated modification conditions of tremella polysaccharide and effects of modifiers on cellular infectivity of NDV,” International Journal of Biological Macromolecules, vol. 49, no. 1, pp. 44–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Meng, J. Huo, W. Lu, X. Wang, J. Zhang, and W. Wang, “Modulation of P1 and EGF expression by Baicalin,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 146–157, 2013. View at Publisher · View at Google Scholar · View at Scopus